Forbes | Is Amarin's Fish-Oil-Derived Drug A Historic Breakthrough Or Not? It's Complicated Forbes Cardiologists are still grappling with clinical trial results released last week that showed that Vascepa, a fish-oil-derived drug, reduced heart attacks, strokes, and deaths from cardiovascular disease by 25% in patients who had elevated triglycerides ... |